Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors

被引:49
|
作者
Ivanenkov, Yan A. [1 ,2 ,3 ]
Vasilevski, Sergei V. [3 ]
Beloglazkina, Elena K. [3 ,5 ]
Kukushkin, Maksim E. [3 ]
Machulkin, Alexey E. [3 ,5 ]
Veselov, Mark S. [2 ]
Chufarova, Nina V. [2 ,8 ]
Chernyaginab, Elizaveta S. [2 ]
Vanzcool, Anton S. [1 ]
Zyk, Nikolay V. [3 ]
Skvortsov, Dmitry A. [3 ]
Khutornenko, Anastasia A. [4 ]
Rusanov, Alexander L. [5 ]
Tonevitsky, Alexander G. [6 ,7 ]
Dontsova, Olga A. [3 ,4 ]
Majouga, Alexander G. [3 ,8 ]
机构
[1] ChemDiv Inc, San Diego, CA 92121 USA
[2] Moscow Inst Phys & Technol, Dolgoprudnyi, Moskovskaya Obl, Russia
[3] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119991, Russia
[4] Moscow MV Lomonosov State Univ, Belozersky Inst, Moscow 119992, Russia
[5] Moscow State Univ Mech Engn MAMI, Moscow, Russia
[6] SRC Bioclinicum, Moscow 115088, Russia
[7] PA Hertsen Moscow Res Oncol Inst, Moscow 125284, Russia
[8] Natl Univ Sci & Technol MISiS, Moscow 119049, Russia
关键词
MDM2/p53; PPI inhibitors; Dispiro-indolinones; 3D molecular docking; Cell-based assay; FACILE SYNTHESIS; P53; CANCER; ISORHYNCHOPHYLLINE; DEGRADATION; DERIVATIVES; ACTIVATION; AUTOPHAGY; PROMOTES; TUMORS;
D O I
10.1016/j.bmcl.2014.09.070
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Regioselective synthesis, biological evaluation and 3D-molecular modeling for a series of novel diastereomeric 2-thioxo-5H-dispiro[imidazolidine-4,3-pyrrolidine-2,3-indole]-2,5(1H)-diones are described. The studied compounds have been tentatively identified as potent small molecule MDM2/p53 PPI inhibitors and can therefore be reasonably regarded as promising anticancer therapeutics. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 50 条
  • [1] Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
    Haohao Zhu
    Hui Gao
    Yingying Ji
    Qin Zhou
    Zhiqiang Du
    Lin Tian
    Ying Jiang
    Kun Yao
    Zhenhe Zhou
    [J]. Journal of Hematology & Oncology, 15
  • [2] Small molecule inhibitors of p53/MDM2 interaction
    Fotouhi, N
    Graves, B
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 159 - 165
  • [3] Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
    Shen, Hong
    Maki, Carl G.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (06) : 560 - 568
  • [4] In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
    Vassilev, LT
    Vu, BT
    Graves, B
    Carvajal, D
    Podlaski, F
    Filipovic, Z
    Kong, N
    Kammlott, U
    Lukacs, C
    Klein, C
    Fotouhi, N
    Liu, EA
    [J]. SCIENCE, 2004, 303 (5659) : 844 - 848
  • [5] Biological evaluation of novel small-molecule activators of p53
    Fedorova, Olga
    Daks, Alexandra
    Petukhov, Alexey
    Shuvalov, Oleg
    Vasileva, Elena
    Barlev, Nickolai
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S39 - S39
  • [6] Design and synthesis of potent, specific and orally active small-molecule inhibitors of the MDM2-p53 interaction
    Yu, Shanghai
    Qin, Dongguang
    Chen, Jianyong
    Wang, Guoping
    Ding, Ke
    Nikolovska-Coleska, Zaneta
    Kumar, Sanjeev
    Qiu, Su
    Bernard, Denzil
    Lu, Yipin
    Kang, Sanmao
    Yang, Daijun
    Wang, Shaomeng
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [7] Synthesis and biological evaluation of 4-imidazolidinone-containing compounds as potent inhibitors of the MDM2/p53 interaction
    Lin, Zhitong
    Liu, Chen
    Yan, Ziqin
    Cheng, Jing
    Wang, Xiancheng
    Zhou, Feilong
    Lyu, Xilin
    Zhang, Shiyan
    Zhang, Daizhou
    Meng, Xiangjing
    Zhao, Yujun
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 270
  • [8] New chemical tools for disrupting the MDM2/p53 protein-protein interaction: Identification, synthesis and biological evaluation of a novel class of MDM2/p53 inhibitors
    Pernazza, Daniele
    Li, Xiaolong
    Lawrence, Harshani R.
    Guida, Wayne C.
    DuBoulay, Courtney J.
    Watts, Shawn
    Sebti, Sayd M.
    Chen, Jiandong
    Lawrence, Nicholas J.
    [J]. CANCER RESEARCH, 2011, 71
  • [9] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [10] Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
    Grinkevich, Vera V.
    Vema, Aparna
    Fawkner, Karin
    Issaeva, Natalia
    Andreotti, Virginia
    Dickinson, Eleanor R.
    Hedstrom, Elisabeth
    Spinnler, Clemens
    Inga, Alberto
    Larsson, Lars-Gunnar
    Karlen, Anders
    Wilhelm, Margareta
    Barran, Perdita E.
    Okorokov, Andrei L.
    Selivanova, Galina
    Zawacka-Pankau, Joanna E.
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9